See more : LOT VACUUM Co., Ltd. (083310.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of Core Laboratories N.V. (CLB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Laboratories N.V., a leading company in the Oil & Gas Equipment & Services industry within the Energy sector.
You may be interested
- Stuhini Exploration Ltd. (STU.V) Income Statement Analysis – Financial Results
- Dana Resources (DANR) Income Statement Analysis – Financial Results
- Corporación Actinver, S. A. B. de C. V. (ACTINVRB.MX) Income Statement Analysis – Financial Results
- Troubadour Resources Inc. (TROUF) Income Statement Analysis – Financial Results
- Cabot Corporation (CBT) Income Statement Analysis – Financial Results
Core Laboratories N.V. (CLB)
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 509.79M | 489.74M | 470.25M | 487.27M | 668.21M | 700.85M | 659.81M | 594.74M | 797.52M | 1.09B | 1.07B | 981.08M | 907.65M | 794.65M | 695.54M | 780.84M | 670.54M | 575.69M | 483.47M | 427.43M | 405.64M | 364.75M | 376.57M | 336.10M | 303.70M | 286.20M | 214.90M | 105.40M | 80.10M |
| Cost of Revenue | 415.74M | 410.82M | 386.41M | 395.63M | 518.18M | 520.05M | 499.18M | 469.52M | 560.11M | 691.97M | 688.44M | 644.74M | 593.37M | 513.79M | 457.77M | 514.78M | 449.19M | 407.10M | 368.12M | 336.39M | 326.92M | 301.31M | 293.31M | 268.66M | 245.40M | 220.50M | 170.50M | 84.70M | 64.20M |
| Gross Profit | 94.05M | 78.92M | 83.84M | 91.63M | 150.03M | 180.80M | 160.63M | 125.23M | 237.41M | 393.26M | 385.07M | 336.34M | 314.28M | 280.86M | 237.77M | 266.05M | 221.35M | 168.59M | 115.34M | 91.04M | 78.72M | 63.44M | 83.26M | 67.44M | 58.30M | 65.70M | 44.40M | 20.70M | 15.90M |
| Gross Profit Ratio | 18.45% | 16.11% | 17.83% | 18.81% | 22.45% | 25.80% | 24.34% | 21.06% | 29.77% | 36.24% | 35.87% | 34.28% | 34.63% | 35.34% | 34.18% | 34.07% | 33.01% | 29.28% | 23.86% | 21.30% | 19.41% | 17.39% | 22.11% | 20.07% | 19.20% | 22.96% | 20.66% | 19.64% | 19.85% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 40.26M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -1.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 38.89M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 41.14M | 33.03M | 30.37M | 31.65M | 33.84M | 33.08M | 37.85M | 28.14M | 22.79M | 20.18M | 15.93M | 13.54M | 12.30M | 8.40M | 6.00M | 3.60M | 2.70M |
| Other Expenses | 515.00K | -722.00K | 5.60M | -1.83M | -5.32M | 737.00K | -452.00K | 344.00K | -3.67M | -1.07M | 338.00K | 4.12M | 22.38M | 20.91M | 20.62M | 28.54M | 3.66M | 11.95M | 16.57M | 16.38M | 22.61M | 22.50M | 27.78M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
| Operating Expenses | 39.41M | 37.40M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 63.53M | 53.94M | 50.99M | 60.19M | 37.50M | 45.03M | 54.41M | 44.52M | 45.40M | 42.68M | 43.71M | 32.76M | 31.00M | 24.90M | 17.00M | 8.20M | 5.80M |
| Cost & Expenses | 455.15M | 448.21M | 430.59M | 429.67M | 566.21M | 582.96M | 546.92M | 508.91M | 609.84M | 737.62M | 740.43M | 687.92M | 656.89M | 567.73M | 508.76M | 574.97M | 486.69M | 452.13M | 422.54M | 380.91M | 372.32M | 343.99M | 337.02M | 301.41M | 276.40M | 245.40M | 187.50M | 92.90M | 70.00M |
| Interest Income | 0.00 | 11.57M | 9.15M | 14.37M | 14.69M | 0.00 | 0.00 | 0.00 | 56.00K | 403.00K | 776.00K | 319.00K | 138.00K | 249.00K | 0.00 | 848.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 13.43M | 11.57M | 9.15M | 14.37M | 14.69M | 13.33M | 10.73M | 11.57M | 12.38M | 10.60M | 9.32M | 8.82M | 10.90M | 15.84M | 15.52M | 6.43M | 0.00 | 0.00 | 0.00 | 0.00 | 7.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 15.78M | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M | 24.52M | 26.87M | 27.46M | 26.70M | 25.47M | 22.92M | 23.30M | 23.27M | 24.33M | 21.77M | 19.48M | 17.69M | 17.06M | 17.40M | 23.54M | 20.10M | 22.54M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
| EBITDA | 70.42M | 58.69M | 63.78M | -56.50M | 119.29M | 141.71M | 134.49M | 114.32M | 188.53M | 373.23M | 358.89M | 316.54M | 271.47M | 247.72M | 210.60M | 231.66M | 203.32M | 141.25M | 77.99M | 63.66M | 56.16M | 40.52M | 62.09M | 53.75M | 39.16M | 57.01M | 41.70M | 17.10M | 13.20M |
| EBITDA Ratio | 13.81% | 11.98% | 13.56% | 15.73% | 17.85% | 20.22% | 20.82% | 14.49% | 23.07% | 31.93% | 31.06% | 30.30% | 30.19% | 31.48% | 30.35% | 29.26% | 28.04% | 23.65% | 17.41% | 14.77% | 13.79% | 11.86% | 18.67% | 15.77% | 19.89% | 20.34% | 17.36% | 16.03% | 16.35% |
| Operating Income | 54.64M | 41.52M | 45.26M | 55.77M | 96.68M | 118.62M | 112.44M | 86.18M | 161.07M | 346.53M | 333.42M | 297.28M | 250.75M | 226.93M | 186.78M | 206.71M | 183.85M | 123.56M | 60.93M | 46.51M | 33.32M | 20.76M | 36.58M | 34.69M | 27.30M | 40.80M | 27.40M | 12.50M | 10.10M |
| Operating Income Ratio | 10.72% | 8.48% | 9.63% | 11.45% | 14.47% | 16.93% | 17.04% | 14.49% | 20.20% | 31.93% | 31.06% | 30.30% | 27.63% | 28.56% | 26.85% | 26.47% | 27.42% | 21.46% | 12.60% | 10.88% | 8.21% | 5.69% | 9.71% | 10.32% | 8.99% | 14.26% | 12.75% | 11.86% | 12.61% |
| Total Other Income/Expenses | -13.43M | -11.57M | -9.15M | -14.37M | -14.69M | -13.33M | -8.26M | -11.57M | -12.38M | -10.60M | -9.32M | -8.82M | -11.91M | -17.78M | -15.52M | 1.55M | -2.55M | -5.81M | -14.29M | -8.28M | -5.07M | -5.38M | -7.92M | -8.31M | -8.56M | -3.92M | -2.60M | -1.30M | -2.80M |
| Income Before Tax | 41.21M | 29.95M | 36.11M | -91.18M | 81.99M | 105.29M | 101.71M | 74.61M | 148.69M | 335.93M | 324.10M | 288.46M | 238.84M | 209.15M | 171.26M | 208.61M | 181.30M | 117.75M | 46.64M | 38.24M | 25.62M | 13.16M | 28.66M | 27.36M | 5.10M | 33.70M | 22.00M | 11.40M | 7.30M |
| Income Before Tax Ratio | 8.08% | 6.12% | 7.68% | -18.71% | 12.27% | 15.02% | 15.41% | 12.54% | 18.64% | 30.96% | 30.19% | 29.40% | 26.31% | 26.32% | 24.62% | 26.72% | 27.04% | 20.45% | 9.65% | 8.95% | 6.32% | 3.61% | 7.61% | 8.14% | 1.68% | 11.77% | 10.24% | 10.82% | 9.11% |
| Income Tax Expense | 4.19M | 10.30M | 15.89M | 5.90M | -12.29M | 25.45M | 18.61M | 10.75M | 33.76M | 77.31M | 80.91M | 71.85M | 54.20M | 63.75M | 57.16M | 65.00M | 60.19M | 35.09M | 14.93M | 10.22M | 6.92M | 5.53M | 8.02M | 8.21M | 1.70M | 10.10M | 6.60M | 3.70M | 2.20M |
| Net Income | 36.68M | 19.45M | 19.73M | -97.07M | 101.98M | 79.53M | 83.13M | 63.90M | 114.85M | 257.49M | 242.81M | 216.07M | 184.68M | 144.92M | 113.60M | 143.60M | 121.11M | 82.66M | 31.21M | 12.29M | 18.70M | -9.06M | 20.63M | 19.15M | 3.40M | 20.00M | 15.40M | 7.70M | 4.20M |
| Net Income Ratio | 7.19% | 3.97% | 4.19% | -19.92% | 15.26% | 11.35% | 12.60% | 10.74% | 14.40% | 23.73% | 22.62% | 22.02% | 20.35% | 18.24% | 16.33% | 18.39% | 18.06% | 14.36% | 6.46% | 2.88% | 4.61% | -2.48% | 5.48% | 5.70% | 1.12% | 6.99% | 7.17% | 7.31% | 5.24% |
| EPS | 0.79 | 0.42 | 0.51 | -2.18 | 2.11 | 1.80 | 1.88 | 1.45 | 2.71 | 5.90 | 5.38 | 4.66 | 3.99 | 3.23 | 2.47 | 2.85 | 2.58 | 1.65 | 0.60 | 0.23 | 0.31 | -0.14 | 0.31 | 0.28 | 0.04 | 0.30 | 0.31 | 0.18 | 0.11 |
| EPS Diluted | 0.77 | 0.42 | 0.50 | -2.16 | 2.10 | 1.79 | 1.88 | 1.45 | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 | 3.00 | 2.43 | 2.74 | 2.48 | 1.54 | 0.56 | 0.22 | 0.30 | -0.14 | 0.30 | 0.27 | 0.04 | 0.29 | 0.30 | 0.17 | 0.11 |
| Weighted Avg Shares Out | 46.68M | 46.33M | 46.01M | 44.48M | 44.36M | 44.21M | 44.15M | 43.48M | 42.38M | 43.64M | 45.10M | 46.35M | 46.29M | 44.83M | 45.94M | 46.02M | 47.07M | 50.31M | 52.08M | 53.79M | 60.42M | 66.35M | 66.15M | 64.78M | 62.90M | 58.45M | 50.32M | 43.43M | 40.00M |
| Weighted Avg Shares Out (Dil) | 47.52M | 46.81M | 46.69M | 44.97M | 44.65M | 44.47M | 44.26M | 44.15M | 42.91M | 44.60M | 45.99M | 47.55M | 48.39M | 48.24M | 46.66M | 47.89M | 48.82M | 53.78M | 56.02M | 57.52M | 62.36M | 66.35M | 68.54M | 67.08M | 64.89M | 60.50M | 52.00M | 44.71M | 40.00M |
CORE LAB REPORTS FIRST QUARTER 2024 RESULTS
FIRST QUARTER REVENUE OF $129.6 MILLION, UP MODESTLY SEQUENTIALLY AND YEAR-OVER-YEAR FIRST QUARTER OPERATING INCOME OF $8.6 MILLION; EX-ITEMS, $14.9 MILLION, FLAT SEQUENTIALLY, UP 3% YEAR-OVER-YEAR FIRST QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FIRST QUARTER GAAP EPS OF $0.07; EX-ITEMS,...
What Makes Core Laboratories (CLB) a New Strong Buy Stock
Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Core Laboratories Inc. (CLB) Q4 2023 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q4 2023 Earnings Call Transcript
Core Laboratories (CLB) Q4 Earnings Miss Estimates, Sales In Line
Core Laboratories' (CLB) first-quarter 2024 revenues are anticipated in the $122-$128 million range, while the operating income is estimated in the band of $11.8-$14.3 million.
Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings
While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street...
Core Laboratories (CLB) Q4 Earnings Miss Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago.
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
FOURTH QUARTER REVENUE OF $128.2 MILLION, UP 2% SEQUENTIALLY FOURTH QUARTER OPERATING INCOME OF $14.6 MILLION; EX-ITEMS, $15.0 MILLION, DOWN 6% SEQUENTIALLY FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.14; EX-ITEMS, $0.19, DOWN 14% SEQUENTIALLY...
Core Laboratories (CLB) Reports Next Week: What You Should Expect
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: https://incomestatements.info
Category: Stock Reports